Search filters

List of works by Rafael Rosell

10(th) Congress on Lung Cancer-updates on clinical trials: goal

scientific article published on April 2014

14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group

scientific article published in December 2005

A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer

article

A critical question for cancer therapy: what new targets exist?

scientific article published on December 2014

A gene signature combining the tissue expression of three angiogenic factors is a prognostic marker in early-stage non-small cell lung cancer.

scientific article

A multicenter randomized phase IIb efficacy study of Vx-001, a peptide-based cancer vaccine as maintenance treatment in advanced non-small-cell lung cancer: treatment rationale and protocol dynamics

scientific article published on 4 May 2013

A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma

scientific article published in September 2008

A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells

scientific article

ALK and ROS1 non-small-cell lung cancer: two molecular subgroups sensitive to targeted therapy

scientific article published on 19 November 2014

ALK translocation and crizotinib in non-small cell lung cancer: An evolving paradigm in oncology drug development ⬇️

scientific article published on March 6, 2012

AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas

scientific article

AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients

scientific article

Abstract 265: Cotargeting EGFR, STAT3 and Src-Notch pathways: a promising approach to improve the efficacy of EGFR-TKIs in the treatment of NSCLC patients

Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP).

scientific article published in August 2017

Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC)

scientific article published on 4 May 2017

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer ⬇️

scientific article published on July 1, 2012

Activation of viral defense signaling in cancer

Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial

scientific article published on 7 November 2016

Adjuvant chemotherapy for resected early-stage non-small cell lung cancer

scientific article

Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation

scientific article published in February 2010

Adjuvant therapy for resected EGFR-mutant non-small-cell lung cancer

scientific article

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

scientific article

Advances and challenges in the molecular biology and treatment of glioblastoma-is there any hope for the future?

scientific article

Advances in immunotherapy for treatment of lung cancer

scientific article

Alectinib: a selective, next-generation ALK inhibitor for treatment of ALK-rearranged non-small-cell lung cancer

scientific article published on 5 February 2015

An innovative mesothelioma treatment based on miR-16 mimic loaded EGFR targeted minicells (TargomiRs).

scientific article published in February 2018

An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer

scientific article published on 26 November 2017

Analysis of the prognostic value of soluble epidermal growth factor receptor plasma concentration in advanced non-small-cell lung cancer patients.

scientific article

Anaplastic lymphoma kinase inhibitors in phase I and phase II clinical trials for non-small cell lung cancer

scientific article

Annual or biennial lung cancer CT screening?

scientific article published on September 2016

Anti-Epidermal Growth Factor Vaccine Antibodies Enhance the Efficacy of Tyrosine Kinase Inhibitors and Delay the Emergence of Resistance in EGFR Mutant Lung Cancer Cells.

scientific article

Applications of genomics in NSCLC.

scientific article

Are we ready to use biomarkers for staging, prognosis and treatment selection in early-stage non-small-cell lung cancer?

scientific article

Assays for predicting and monitoring responses to lung cancer immunotherapy

scientific article published on June 2015

Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial

scientific article published on May 2015

BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

scientific article

BIM deletion polymorphisms in Hispanic patients with non-small cell lung cancer carriers of EGFR mutations

scientific article published on September 2016

BRAF mutant non-small cell lung cancer and treatment with BRAF inhibitors

scientific article

BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitors

scientific article published on 11 September 2015

BRAFV600E and BRAF-inactivating mutations in NSCLC.

scientific article published on 8 September 2017

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

scientific article

BRCA1, LMO4, and CtIP mRNA Expression in Erlotinib-Treated Non–Small-Cell Lung Cancer Patients with EGFR Mutations ⬇️

scientific article published on March 1, 2013

BRCA1: a new genomic marker for non-small-cell lung cancer

scientific article

BRCA1: a novel prognostic factor in resected non-small-cell lung cancer

scientific article

Beta-tubulin mutational analysis: tantalizing findings

scientific article published in October 2002

Beyond platinum treatment for NSCLC: what does the future hold?

scientific article published on 27 January 2017

Biomarkers in lung oncology

scientific article published on 13 May 2010

Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients

scientific article published on 5 September 2009

Brain metastases in patients with EGFR-mutant non-small-cell lung cancer

scientific article published on 19 July 2017

Bronchioloalveolar carcinoma: a review

scientific article

CK-coated magnetic-based beads as a tool to isolate circulating tumor cells (CTCs) in human tumors

scientific article published on April 2013

Can We Customize Chemotherapy? Individualizing Cytotoxic Regimens in Advanced Non–Small-Cell Lung Cancer ⬇️

scientific article published on March 1, 2008

Cancer stem cells and immunoresistance: clinical implications and solutions

scientific article

Cancer stem cells in small cell lung cancer

scientific article

Cancer treatments: can we find treasures at the bottom of the sea?

scientific article published on July 2009

Challenges and unanswered questions for the next decade of immune-oncology research in NSCLC

article by Niki Karachaliou et al published December 2018 in Translational lung cancer research

Chemotherapy-induced neutropenia does not correlate with DNA repair gene polymorphisms and treatment efficacy in advanced non-small-cell lung cancer patients

scientific article published on 24 April 2011

Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer.

scientific article

Cisplatin plus vinorelbine as first-line treatment for advanced non-small-cell lung cancer: Is a hemogram on day 8 essential?

scientific article published on 19 August 2009

Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphisms

scientific article published on 12 March 2008

Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis

scientific article

Clinical assessment of immune-related adverse events.

scientific article published on 30 March 2018

Clinical experience with erlotinib in non-small-cell lung cancer

scientific article

Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis

scientific article published on 08 December 2009

Clinical significance of hypoxia-inducible factor-1a messenger RNA expression in locally advanced non-small-cell lung cancer after platinum agent and gemcitabine chemotherapy followed by surgery

scientific article published in March 2005

Cloning and characterization of the promoter of human Wnt inhibitory factor-1.

scientific article

Co-mutations in EGFR driven non-small cell lung cancer

Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?

scientific article published on 6 April 2018

Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC).

scientific article published on 9 January 2018

Comprehensive molecular screening: from the RT-PCR to the RNA-seq

scientific article

Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop

scientific article published on October 2010

Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer

scientific article published on 4 September 2017

Coordinated strategies for early detection of lung cancer.

scientific article

Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery

scientific article published on 9 November 2016

Crossing the rubicon in lung adenocarcinoma: the conundrum of EGFR tyrosine kinase mutations

scientific article

Current concepts in bronchioloalveolar carcinoma biology

scientific article (publication date: 15 June 2006)

Customized chemotherapy in metastatic non-small cell lung cancer (NSCLC)

scientific article published on June 2013

Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression

scientific article

DNA repair and cisplatin resistance in non-small-cell lung cancer

scientific article

Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer

scientific article

Determinants of response and resistance to cytotoxics

scientific article

Disulfide isomerase family-6 mediates cisplatin resistance by interfering with apoptosis and autophagy

Early evolution of BRAFV600 status in the blood of melanoma patients correlates with clinical outcome and identifies patients refractory to therapy

scientific article

Early2 factor (E2F) deregulation is a prognostic and predictive biomarker in lung adenocarcinoma

scientific article published on 14 October 2016

Economic Analysis of First-Line Treatment with Erlotinib in an EGFR-Mutated Population with Advanced NSCLC.

scientific article

Effect of the methylenetetrahydrofolate reductase C677T polymorphism on patients with cisplatin/gemcitabine-treated stage IV non-small-cell lung cancer

scientific article

Emerging drugs for non-small-cell lung cancer

scientific article published on September 2007

Endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of intrathoracic lymph node metastases from extrathoracic malignancies ⬇️

scientific article published on November 30, 2012

Epidermal growth factor receptor activation: how exon 19 and 21 mutations changed our understanding of the pathway

scientific article published on December 2006

Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in advanced nonsmall-cell lung cancer

scientific article published on March 2010

Epigenetic alterations of tumor marker microRNAs: Towards new cancer therapies

scientific article published on December 1, 2010

Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial

scientific article published on 10 April 2017

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

scientific article

Erlotinib-associated rash in patients with EGFR mutation-positive non-small-cell lung cancer treated in the EURTAC trial

scientific article published on January 2015

Erratum to Assays for predicting and monitoring responses to lung cancer immunotherapy

scientific article published in September 2015

Evaluation of Biomarkers for HER3-targeted Therapies in Cancer

scientific article published on 16 February 2015

Expression Profiles and Clinicopathologic Features in Early Resected Non-small-cell Lung Cancer

scientific article published on 22 October 2014

FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR.

scientific article published on March 2011

First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients

scientific article published on 11 August 2010

From the bench to the bed: individualizing treatment in non-small-cell lung cancer

scientific article

Front-line erlotinib in unselected patients with advanced NSCLC and poor performance status - the TOPICAL study

scientific article published on February 2013

Future directions in the second-line treatment of non-small cell lung cancer

scientific article

Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1.

scientific article

Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 2.

scientific article

Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival

scientific article

Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery

scientific article

Genetic testing for chemotherapy in non-small cell lung cancer

scientific article

Genetics and biomarkers in personalisation of lung cancer treatment ⬇️

scientific article published on August 24, 2013

Genome-Wide Association Study of Survival in Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy ⬇️

scientific article published on April 11, 2011

Genotyping Non-small Cell Lung Cancer (NSCLC) in Latin America ⬇️

scientific article published on November 1, 2011

HER3 as a Therapeutic Target in Cancer

scientific article published on 20 December 2016

High BIM mRNA levels are associated with longer survival in advanced gastric cancer

scientific article

Homage to the titans of Chinese investigation and the race for lung cancer curability

scientific article published in October 2017

How to optimize the treatment strategy for patients with EGFR-mutant stage IA lung adenocarcinoma: an international multidisciplinary team.

scientific article published in June 2018

Human endogenous retroviruses and cancer

scientific article published in December 2016

IL-6/gp130/STAT3 signaling axis in cancer and the presence of in-frame gp130 somatic deletions in inflammatory hepatocellular tumors

scientific article

Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer Patients

scientific article published on 10 January 2017

Immunotherapy meets targeted therapy: will this team end the war against cancer?

scientific article

Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-Analysis.

scientific article

Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Rando

scientific article published on 24 April 2008

Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.

scientific article

Inhibition of MEK, a canonical KRAS pathway effector in mutant NSCLC

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

scientific article

Interstitial lung disease arising from erlotinib treatment in a Caucasian patient.

scientific article published on 21 November 2014

Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer?

scientific article

KRAS Mutations in Lung Cancer ⬇️

scientific article published on November 1, 2012

Liquid Biopsy in Non-Small Cell Lung Cancer

scientific article published on 23 December 2016

Liquid biopsy for lung cancer early detection.

scientific article

Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901.

scientific article published in October 2007

Loss of activating EGFR mutant gene contributes to acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer cells

scientific article

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

scientific article

Low RAP80 mRNA expression correlates with shorter survival in sporadic high-grade serous ovarian carcinoma

scientific article published on 18 July 2016

Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group

scientific article published on 27 May 2008

Lung cancer and treatment in elderly patients: the Achilles Study

scientific article

Lung cancer in 2014: optimizing lung cancer treatment approaches

scientific article published on 23 December 2014

Lung cancer: Using ctDNA to track EGFR and KRAS mutations in advanced-stage disease

scientific article published in June 2016

Lungscape: resected non-small-cell lung cancer outcome by clinical and pathological parameters

MET overexpression and amplification define a distinct molecular subgroup for targeted therapies in gastric cancer

scientific article published on 24 September 2015

Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes

scientific article published on 17 July 2013

Mediating Resistance in Oncogene-Driven Cancers ⬇️

scientific article published on April 18, 2013

Meta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancer

scientific article

Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients ⬇️

scientific article published on April 25, 2003

Molecular Bases for Combinatorial Treatment Strategies in Patients with KRAS Mutant Lung Adenocarcinoma and Squamous Cell Lung Carcinoma

Molecular biomarkers for predicting chemotherapy response in lung cancer ⬇️

scientific article published on 07 September 2009

Molecular markers and targeted therapy with novel agents: prospects in the treatment of non-small cell lung cancer

scientific article

Molecular predictors of response to chemotherapy in lung cancer

scientific article published on February 2004

Mouse p53-deficient cancer models as platforms for obtaining genomic predictors of human cancer clinical outcomes

scientific article published on 7 August 2012

Moving towards molecular-guided treatments: erlotinib and clinical outcomes in non-small-cell lung cancer patients

scientific article

Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer

scientific article

Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers vs. Heavy Smokers (Geno1.3-CLICaP)

article published in 2019

Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer

scientific article published in October 2005

Neoadjuvant treatment of early-stage resectable non-small-cell lung cancer

scientific article published in December 2004

Neutrophils dominate the immune landscape of non-small cell lung cancer

scientific article published on May 2017

No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: a meta-analysis

scientific article

Non-small-cell lung cancer harbouring mutations in the EGFR kinase domain

scientific article published on February 2010

Non-small-cell lung cancer.

scientific article published on 21 May 2015

Nondisruptive p53 mutations are associated with shorter survival in patients with advanced non-small cell lung cancer.

scientific article

Nucleotide excision repair pathways involved in Cisplatin resistance in non-small-cell lung cancer

scientific article

O.01: Acquired Resistance to EGFR-TKIs in EGFR-Mutant Lung Adenocarcinoma Among Hispanics (RBIOP-CLICaP).

scientific article

O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme

scientific article published in April 2003

Optimal Detection of ALK Rearranged Lung Adenocarcinomas ⬇️

scientific article published on March 1, 2013

Optimization of genetics to create therapies for metastatic (stage IV) non-small-cell lung cancer

scientific article published on July 2010

Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy

scientific article published on 18 August 2017

Osimertinib in untreated epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer.

scientific article

Other targeted drugs in melanoma

scientific article

Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers

scientific article (publication date: 23 August 2002)

P1.42 (also presented as PD2.04): PEM/CBP/BEV Followed by Maintenance PEM/BEV in Hispanic Patients With NSCLC: Outcomes According to TS, ERCC1 and VEGF: Track: Advanced NSCLC.

scientific article

P2.04: Characteristics and Long Term Outcomes of Advanced Pleural Mesothelioma in Latin America (MeSO-CLICaP): Track: SCLC, Mesothelioma, Thymoma

scientific article

PD-L1 expression associated with better response to EGFR tyrosine kinase inhibitors

scientific article published in June 2015

PET/CT fusion scan in lung cancer: current recommendations and innovations

scientific article published on January 2006

PIK3CA mutations and BRCA1 expression in breast cancer: potential biomarkers for chemoresistance

scientific article published on December 2008

Pathway Targeted Immunotherapy: Rationale and Evidence of Durable Clinical Responses with a Novel, EGF-directed Agent for Advanced NSCLC.

scientific article

Pemetrexed combination therapy in the treatment of non-small cell lung cancer

scientific article

Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial

scientific article

Pemetrexed in front-line chemotherapy for advanced non-small-cell lung cancer

scientific article

Pemetrexed/Carboplatin/Bevacizumab followed by Maintenance Pemetrexed/Bevacizumab in Hispanic Patients with Non-Squamous Non-Small Cell Lung Cancer: Outcomes according to Thymidylate Synthase Expression

scientific article

Personalized treatment in advanced ALK-positive non-small cell lung cancer: from bench to clinical practice

scientific article

Personalized treatment of early-stage non-small-cell lung cancer: the challenging role of EGFR inhibitors

scientific article published on January 2015

Pharmacogenetics of EGFR in Lung Cancer: Perspectives and Clinical Applications ⬇️

scientific article published on May 1, 2012

Pharmacogenomic approaches to individualizing chemotherapy for non-small-cell lung cancer: current status and new directions

scientific article published on January 2008

Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer

scientific article

Pharmacogenomics in lung cancer: an analysis of DNA repair gene expression in patients treated with platinum-based chemotherapy

scientific article

Pharmacogenomics in non-small-cell lung cancer chemotherapy

scientific article published on 16 March 2009

Pharmacogenomics in the treatment of lung cancer: an update

scientific article published on 02 October 2015

Pharmacological management of relapsed/refractory NSCLC with chemical drugs

scientific article published on 20 January 2017

Phase I, dose-escalating study of elisidepsin (Irvalec(®)), a plasma membrane-disrupting marine antitumor agent, in combination with erlotinib in patients with advanced malignant solid tumors

scientific article published on 2 December 2015

Phase I/II and pharmacokinetic study of intravenous vinflunine in combination with cisplatin for the treatment of chemonaive patients with advanced non-small-cell lung cancer

scientific article published in March 2010

Phase II non-randomized study of three different sequences of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer

scientific article published on December 2002

Plasma mRNA expression levels of BRCA1 and TS as potential predictive biomarkers for chemotherapy in gastric cancer

scientific article

Platinum drugs and DNA repair mechanisms in lung cancer

scientific article published on January 2014

Platinum resistance related to a functional NER pathway

scientific article published on December 2007

Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy

scientific article

Possible application of circulating free tumor DNA in non-small cell lung cancer patients

scientific article published in October 2017

Predicting Response to Chemotherapy With Early-Stage Lung Cancer ⬇️

scientific article published on January 1, 2011

Predicting resistance by selection of signaling pathways

scientific article published on April 2014

Predicting the outcome of chemotherapy for lung cancer

scientific article published on 12 June 2006

Predictive biomarkers in the management of EGFR mutant lung cancer ⬇️

scientific article published on October 1, 2010

Predictive factors for immunotherapy in melanoma

scientific article

Predictors of long-term survival in patients with lung cancer included in the randomized Spanish Lung Cancer Group 0008 phase II trial using concomitant chemoradiation with docetaxel and carboplatin plus induction or consolidation chemotherapy

scientific article published in May 2009

Pretreatment EGFR T790M Mutation and BRCA1 mRNA Expression in Erlotinib-Treated Advanced Non–Small-Cell Lung Cancer Patients with EGFR Mutations ⬇️

scientific article published on January 13, 2011

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer

scientific article published on February 2016

Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta role

scientific article

Prospective randomized phase III trial of etoposide/cisplatin versus high-dose epirubicin/cisplatin in small-cell lung cancer

scientific article published in November 2004

Quantification of unmethylated Alu (QUAlu): a tool to assess global hypomethylation in routine clinical samples

scientific article published on 07 February 2016

RET inhibitors for patients with RET fusion-positive and RET wild-type non-small-cell lung cancer

scientific article

ROR1 as a novel therapeutic target for EGFR-mutant non-small-cell lung cancer patients with the EGFR T790M mutation

scientific article

ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability

scientific article published in April 2015

Randomized phase II trial of non-platinum induction or consolidation chemotherapy plus concomitant chemoradiation in stage III NSCLC patients: mature results of the Spanish Lung Cancer Group 0008 study

scientific article published on 21 April 2013

Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (Toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancer

scientific article

Real-time liquid biopsies become a reality in cancer treatment

scientific article

Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer

scientific article published on 2 November 2015

Recent developments in the use of immunotherapy in non-small cell lung cancer

scientific article published on 5 May 2016

Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology

scientific article published on 24 December 2009

Relationship between gene mutation and lung cancer metastasis

scientific article published on June 2015

Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies

scientific article published on April 2013

Response to crizotinib in a non-small-cell lung cancer patient harboring an EML4-ALK fusion with an atypical LTBP1 insertion

scientific article

Results of clinical trials with anti-programmed death 1/programmed death ligand 1 inhibitors in lung cancer

scientific article

Retrospective analysis of the prognostic role of p16 protein inactivation in plasma in patients with locally advanced non-small cell lung cancer

scientific article published on 19 February 2008

Retrospective study of efficacy and toxicity on patients older than 70 years within a randomized clinical trial of two cisplatin-based combinations in patients with small-cell lung cancer

scientific article published on 13 June 2008

Rhomboids and regulation of receptor tyrosine kinase ligands shedding

scientific article published on 06 October 2018

Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevance

scientific article published in February 2005

Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients

scientific article published in February 2004

Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer ⬇️

scientific article published on June 1, 2010

Role of genotyping in non-small cell lung cancer treatment: current status

scientific article published on December 2011

SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer

scientific article

STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer

scientific article published on 2 April 2018

Science and biology drives the immune system to cure lung cancer patients: a revolution but not without challenges.

scientific article published on 22 March 2018

Screening for EGFR mutations in lung cancer.

scientific article published in December 2009

Second-line therapy of squamous non-small cell lung cancer: an evolving landscape

scientific article published on 3 May 2017

Second-line treatment in EGFR-unselected patients: is it time to close one arm of this river's DELTA?

scientific article

Second-line treatment of advanced non-small cell lung cancer

scientific article published in April 2008

Setting the benchmark for tailoring treatment with EGFR tyrosine kinase inhibitors

scientific article published on June 2007

Signaling pathways modulating dependence of lung cancer on mutant epidermal growth factor receptor and mechanisms of intrinsic and acquired resistance to tyrosine kinase inhibitors

scientific article published on January 2014

Single nucleotide polymorphisms (SNPs) in non-small cell lung cancer (NSCLC) patients

scientific article published on 26 September 2012

Small-Cell Lung Cancer: Where are we Now and What Can We Expect for the Future? ⬇️

scientific article published on August 1, 2013

Smoking habits in elderly lung cancer patients: still no changes in epidemiology? A single-center experience ⬇️

scientific article published on October 1, 2010

Spotlight on ceritinib in the treatment of ALK+ NSCLC: design, development and place in therapy

scientific article

Strategies for first-line immunotherapy in squamous cell lung cancer: are combinations a game changer?

Strategies to overcome resistance to tyrosine kinase inhibitors in non-small-cell lung cancer

scientific article published on 11 June 2015

Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection

scientific article

Successful empirical erlotinib treatment of a mechanically ventilated patient newly diagnosed with metastatic lung adenocarcinoma

scientific article published on 24 July 2014

Survival Outcomes According to TIMP1 and EGFR Expression in Heavily Treated Patients with Advanced Non-small Cell Lung Cancer who Received Biweekly Irinotecan Plus Bevacizumab

scientific article

Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyond

scientific article published on 10 March 2014

Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyond

scientific article published on September 2014

Targeted drugs in small-cell lung cancer

scientific article

Targeted treatment of mutated EGFR-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnostics

scientific article published on 13 November 2014

Targeting PD-1/PD-L1 in lung cancer: current perspectives

scientific article published on 31 July 2015

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry

scientific article

Testing for excision repair cross-complementing 1 in patients with non-small-cell lung cancer for chemotherapy response

scientific article published on May 2007

The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

scientific article published on 09 February 2015

The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring

scientific article published on 20 July 2018

The Value of Early Depth of Response in Predicting Long-Term Outcome in EGFR-Mutant Lung Cancer

scientific article

The combination of checkpoint immunotherapy and targeted therapy in cancer

scientific article published in October 2017

The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer

scientific article published on 6 March 2015

The epidermal growth factor receptor (EGRF) in lung cancer

scientific article

The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial

scientific article published on 3 February 2014

The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer

scientific article published on 18 December 2014

The impact of rare EGFR mutations on the treatment response of patients with non-small cell lung cancer.

scientific article

The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy

scientific article published on October 2013

The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancer

scientific article

The promise of pharmacogenomics: gemcitabine and pemetrexed.

scientific article

The role of Wnt signaling in cancer and stem cells

scientific article

The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet che

scientific article

The role of the clinical research coordinator--data manager--in oncology clinical trials

scientific article

Toward customized trastuzumab in HER-2/neu-overexpressing non-small-cell lung cancers

scientific article published on 23 February 2004

Transcriptomic-metabolomic reprogramming in EGFR-mutant NSCLC early adaptive drug escape linking TGFβ2-bioenergetics-mitochondrial priming

scientific article published on 11 November 2016

Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer

scientific article

Translational oncogenomics: toward rational therapeutic decision-making

scientific article

Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel

scientific article

Treatment of brain metastases in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations: the role of EGFR tyrosine kinase inhibitors

scientific article published on July 2013

Treatment of non-small-cell lung cancer and pharmacogenomics: where we are and where we are going

scientific article

Trends in immunotherapy for brain metastases

scientific article published on 3 June 2016

Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients

scientific article

Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patients

scientific article published in September 2011

Tyrosine kinase inhibitors for non-small-cell lung cancer: finding patients who will be responsive

scientific article published on June 2011

Understanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpoints

scientific article

Unraveling the genomic complexity of small cell lung cancer

scientific article published on August 2016

Usefulness of circulating free DNA for monitoring epidermal growth factor receptor mutations in advanced non-small cell lung cancer patients: a case report

scientific article published on October 2016

Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphism ⬇️

scientific article published on November 1, 2003

Weighing tumor biology in treatment decisions for patients with non-small cell lung cancer

scientific article published on June 2007

What new therapeutic targets exist for EGFR-mutant NSCLC?

scientific article published on 27 August 2014

Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer

scientific article published in July 2004

Wnt signaling in stem cells and non-small-cell lung cancer

scientific article

XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression

scientific article published in January 2009

YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma

scientific article published on 29 May 2017

c-Met Mutational Analysis in the Sema and Juxtamembrane Domains in Small-Cell-Lung-Cancer ⬇️

scientific article published on September 21, 2006

cfDNA analysis from blood in melanoma

scientific article

mRNA Expression of BRCA1, PIAS1, and PIAS4 and Survival After Second-line Docetaxel in Advanced Gastric Cancer ⬇️

scientific article (publication date: 19 October 2011)

mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients ⬇️

scientific article published on September 27, 2011

Paulina is supported by:

About Paulina

Help